Delivery Order SPE2DB22D3010-SPE2DB24FP2UW

Award Date 7/12/24
Potential Completion Date 7/15/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $56,487.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIVALO 2 MG TABLET 90S, a pharmaceutical product, and has an ultimate completion date of December 12, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued...
This federal contract award, valued at $1,159.66, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract provides for the delivery of LIVALO 2 MG TABLET 90S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of May 31, 2024 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This federal contract award, valued at $1,763.44, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIVALO 2 MG TABLET 90S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of June 27, 2024 and is a Firm Fixed Price Delivery Order. The contract is not associated with a set-aside designation,...
This federal contract award, valued at $4,871.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of LIVALO 4 MG TABLET 90S, a pharmaceutical product, with a completion date of December 10, 2024. The award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $17,208.45, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract provides for the delivery of LIVALO 4 MG TABLET 90S, a pharmaceutical product, with a performance period ending on May 10, 2023. The contract has no set-aside...
This federal contract award, valued at $2,540.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The contract provides for the delivery of LIVALO 2 MG TABLET 90S, a pharmaceutical product, to support military healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,373.61 firm fixed-price delivery order is for the provision of LIVALO 1 MG TABLET 90S, a prescription medication. The contract has an ultimate completion date of December 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,711.72, is a delivery order for the supply of LIVALO 4 MG TABLET 90S, a prescription medication. The contract has an ultimate completion date of October 31, 2024 and is a firm fixed-price contract. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any set-aside...
This federal contract award is for the delivery of LIVALO 1 MG TAB 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $3,919.62 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 23, 2024 and is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds...
This federal contract award, with ID SPE2DX15D1053|SPE2DX24F6MBP, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,806.70 firm fixed-price delivery order is for the supply of LIVALO 1 MG TABLET 90S, with a period of performance through May 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB22D3010
    Indefinite Delivery Contract
  • SPE2DB22D3010-SPE2DB24FP2UW
    Delivery Order

This federal contract award, valued at $1,363.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIVALO 4 MG TABLET 90S, a pharmaceutical product, with a completion date of July 15, 2024.

The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award does not have a set-aside designation, indicating open competition.

Generated 5/17/25, 10:00 AM